Knollwood Investment Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Knollwood Investment Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	+1,553	New	+$210K	0.02%	246
2025 Q2	–	Sell	-8,173	Closed	-$663K	–	362
2025 Q1	$663K	Hold	8,173	–	–	0.07%	225
2024 Q4	$736K	Hold	8,173	–	–	0.08%	223
2024 Q3	$807K	Hold	8,173	–	–	0.09%	223
2024 Q2	$758K	Sell	8,173 -5,500	-40%	-$493K	0.08%	219
2024 Q1	$1.3M	Hold	13,673	–	–	0.23%	82
2023 Q4	$1.22M	Hold	13,673	–	–	0.25%	82
2023 Q3	$998K	Hold	13,673	–	–	0.47%	57
2023 Q2	$1.14M	Hold	13,673	–	–	0.38%	70
2023 Q1	$1.04M	Hold	13,673	–	–	0.2%	76
2022 Q4	$1.13M	Buy	+13,673	New	+$1.11M	0.44%	58

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Knollwood Investment Advisory's XBI Position: Q2 2026 in Review

Knollwood Investment Advisory opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,553 shares worth $246K. The stake represents 0.02% of the portfolio and ranks #246 among its holdings. This is a return to the name: Knollwood Investment Advisory previously reported a position in XBI as recently as Q1 2025.

Knollwood Investment Advisory first reported a position in XBI in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.3M in Q1 2024. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Knollwood Investment Advisory held 1,553 shares of State Street SPDR S&P Biotech ETF worth $246K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Knollwood Investment Advisory position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Knollwood Investment Advisory's portfolio in Q2 2026, its #246 holding.
Knollwood Investment Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 11 quarters since.
Knollwood Investment Advisory's State Street SPDR S&P Biotech ETF position peaked at $1.3M in Q1 2024.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.